167 related articles for article (PubMed ID: 16721367)
1. Production and upregulation of granulocyte chemotactic protein-2/CXCL6 by IL-1beta and hypoxia in small cell lung cancer.
Zhu YM; Bagstaff SM; Woll PJ
Br J Cancer; 2006 Jun; 94(12):1936-41. PubMed ID: 16721367
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-8/CXCL8 is a growth factor for human lung cancer cells.
Zhu YM; Webster SJ; Flower D; Woll PJ
Br J Cancer; 2004 Nov; 91(11):1970-6. PubMed ID: 15545974
[TBL] [Abstract][Full Text] [Related]
3. Differential usage of the CXC chemokine receptors 1 and 2 by interleukin-8, granulocyte chemotactic protein-2 and epithelial-cell-derived neutrophil attractant-78.
Wuyts A; Proost P; Lenaerts JP; Ben-Baruch A; Van Damme J; Wang JM
Eur J Biochem; 1998 Jul; 255(1):67-73. PubMed ID: 9692902
[TBL] [Abstract][Full Text] [Related]
4. Granulocyte chemotactic protein 2 acts via both IL-8 receptors, CXCR1 and CXCR2.
Wolf M; Delgado MB; Jones SA; Dewald B; Clark-Lewis I; Baggiolini M
Eur J Immunol; 1998 Jan; 28(1):164-70. PubMed ID: 9485196
[TBL] [Abstract][Full Text] [Related]
5. GCP-2-induced internalization of IL-8 receptors: hierarchical relationships between GCP-2 and other ELR(+)-CXC chemokines and mechanisms regulating CXCR2 internalization and recycling.
Feniger-Barish R; Belkin D; Zaslaver A; Gal S; Dori M; Ran M; Ben-Baruch A
Blood; 2000 Mar; 95(5):1551-9. PubMed ID: 10688807
[TBL] [Abstract][Full Text] [Related]
6. Rabbit neutrophil chemotactic protein (NCP) activates both CXCR1 and CXCR2 and is the functional homologue for human CXCL6.
Catusse J; Struyf S; Wuyts A; Weyler M; Loos T; Gijsbers K; Gouwy M; Proost P; Van Damme J
Biochem Pharmacol; 2004 Nov; 68(10):1947-55. PubMed ID: 15476666
[TBL] [Abstract][Full Text] [Related]
7. CXCR1-binding chemokines in inflammatory bowel diseases: down-regulated IL-8/CXCL8 production by leukocytes in Crohn's disease and selective GCP-2/CXCL6 expression in inflamed intestinal tissue.
Gijsbers K; Van Assche G; Joossens S; Struyf S; Proost P; Rutgeerts P; Geboes K; Van Damme J
Eur J Immunol; 2004 Jul; 34(7):1992-2000. PubMed ID: 15214047
[TBL] [Abstract][Full Text] [Related]
8. Studies on the expression of endothelin, its receptor subtypes, and converting enzymes in lung cancer and in human bronchial epithelium.
Ahmed SI; Thompson J; Coulson JM; Woll PJ
Am J Respir Cell Mol Biol; 2000 Apr; 22(4):422-31. PubMed ID: 10745023
[TBL] [Abstract][Full Text] [Related]
9. Characterization of synthetic human granulocyte chemotactic protein 2: usage of chemokine receptors CXCR1 and CXCR2 and in vivo inflammatory properties.
Wuyts A; Van Osselaer N; Haelens A; Samson I; Herdewijn P; Ben-Baruch A; Oppenheim JJ; Proost P; Van Damme J
Biochemistry; 1997 Mar; 36(9):2716-23. PubMed ID: 9054580
[TBL] [Abstract][Full Text] [Related]
10. Granulocyte chemotactic protein-2 mediates adaptive immunity in part through IL-8Rbeta interactions.
Singh UP; Singh S; Boyaka PN; McGhee JR; Lillard JW
J Leukoc Biol; 2004 Dec; 76(6):1240-7. PubMed ID: 15356099
[TBL] [Abstract][Full Text] [Related]
11. NH2- and COOH-terminal truncations of murine granulocyte chemotactic protein-2 augment the in vitro and in vivo neutrophil chemotactic potency.
Wuyts A; D'Haese A; Cremers V; Menten P; Lenaerts JP; De Loof A; Heremans H; Proost P; Van Damme J
J Immunol; 1999 Dec; 163(11):6155-63. PubMed ID: 10570306
[TBL] [Abstract][Full Text] [Related]
12. Effects of COX-2 inhibition on expression of vascular endothelial growth factor and interleukin-8 in lung cancer cells.
Zhu YM; Azahri NS; Yu DC; Woll PJ
BMC Cancer; 2008 Jul; 8():218. PubMed ID: 18671849
[TBL] [Abstract][Full Text] [Related]
13. Neutral endopeptidase: variable expression in human lung, inactivation in lung cancer, and modulation of peptide-induced calcium flux.
Cohen AJ; Bunn PA; Franklin W; Magill-Solc C; Hartmann C; Helfrich B; Gilman L; Folkvord J; Helm K; Miller YE
Cancer Res; 1996 Feb; 56(4):831-9. PubMed ID: 8631021
[TBL] [Abstract][Full Text] [Related]
14. CXCR1/2 antagonism with CXCL8/Interleukin-8 analogue CXCL8(3-72)K11R/G31P restricts lung cancer growth by inhibiting tumor cell proliferation and suppressing angiogenesis.
Khan MN; Wang B; Wei J; Zhang Y; Li Q; Luan X; Cheng JW; Gordon JR; Li F; Liu H
Oncotarget; 2015 Aug; 6(25):21315-27. PubMed ID: 26087179
[TBL] [Abstract][Full Text] [Related]
15. HIF-1 and NF-kappaB-mediated upregulation of CXCR1 and CXCR2 expression promotes cell survival in hypoxic prostate cancer cells.
Maxwell PJ; Gallagher R; Seaton A; Wilson C; Scullin P; Pettigrew J; Stratford IJ; Williams KJ; Johnston PG; Waugh DJ
Oncogene; 2007 Nov; 26(52):7333-45. PubMed ID: 17533374
[TBL] [Abstract][Full Text] [Related]
16. Production of neuromedin B and neuromedin B gene expression in human lung tumor cell lines.
Cardona C; Rabbitts PH; Spindel ER; Ghatei MA; Bleehen NM; Bloom SR; Reeve JG
Cancer Res; 1991 Oct; 51(19):5205-11. PubMed ID: 1717141
[TBL] [Abstract][Full Text] [Related]
17. The CXC chemokine GCP-2/CXCL6 is predominantly induced in mesenchymal cells by interleukin-1beta and is down-regulated by interferon-gamma: comparison with interleukin-8/CXCL8.
Wuyts A; Struyf S; Gijsbers K; Schutyser E; Put W; Conings R; Lenaerts JP; Geboes K; Opdenakker G; Menten P; Proost P; Van Damme J
Lab Invest; 2003 Jan; 83(1):23-34. PubMed ID: 12533683
[TBL] [Abstract][Full Text] [Related]
18. Secretion of granulocyte chemotactic protein-2 by cultured human endometrial stromal cells.
Mine S; Nasu K; Fukuda J; Sun B; Miyakawa I
Fertil Steril; 2003 Jan; 79(1):146-50. PubMed ID: 12524079
[TBL] [Abstract][Full Text] [Related]
19. Differential regulation of ENA-78 and GCP-2 gene expression in human corneal keratocytes and epithelial cells.
Fillmore RA; Nelson SE; Lausch RN; Oakes JE
Invest Ophthalmol Vis Sci; 2003 Aug; 44(8):3432-7. PubMed ID: 12882792
[TBL] [Abstract][Full Text] [Related]
20. Functional expression of CXCR4 (CD184) on small-cell lung cancer cells mediates migration, integrin activation, and adhesion to stromal cells.
Burger M; Glodek A; Hartmann T; Schmitt-Gräff A; Silberstein LE; Fujii N; Kipps TJ; Burger JA
Oncogene; 2003 Nov; 22(50):8093-101. PubMed ID: 14603250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
